NIH selects UAB’s Dr. Jeanne Marrazzo to replace Dr. Anthony Fauci
Dr. Jeanne Marrazzo speaks during a press conference September 3, 2020.
Officials with the National Institutes of Health (NIH) have selected UAB infectious disease specialist Dr. Jeanne Marrazzo to replace Dr. Anthony Fauci as the next director of National Institute of Allergy and Infectious Diseases (NIAID).
“Dr. Marrazzo brings a wealth of leadership experience from leading international clinical trials and translational research, managing a complex organizational budget that includes research funding and mentoring trainees in all stages of professional development,” said Dr. Lawrence Tabak, acting director for the NIH, in an announcement Wednesday.
Marrazzo has directed UAB’s Division of Infectious Diseases since 2016 and has been a leading voice throughout the COVID-19 pandemic for both local and national audiences.
“Jeanne served as a trusted advisor and friend who gave us the insights, guidance and confidence that allowed our institution to thrive in spite of immense challenges,” UAB president Ray Watts said in a statement. “This is a great opportunity for Dr. Marrazzo to make a big difference to the country, and it is indicative of the high regard that exists for both her and UAB. While we are sad to see her go, we are delighted that Jeanne has been called to this national service and we are proud to count her as one of us at UAB.”
Marrazzo obtained her bachelor’s in biology from Harvard University, a medical degree from Thomas Jefferson University and a Master of Public Health in Epidemiology from the University of Washington. Her research has focused on the human microbiome, including female reproductive tract infections, and sexually transmitted diseases like HIV.
In her new role at the NIH, Marrazzo will oversee a $6.3 billion budget that funds nationwide research into new therapies, vaccines and diagnostic technologies for a range of infectious diseases. According to NIH officials, she is expected to begin the position this fall.
Trump signs executive action to lower drug prices
The action is intended to build upon the existing program for Medicare drug price negotiations, which was created by the Inflation Reduction Act that passed during the Biden administration.
New Israeli ceasefire offer demands Hamas discuss disarming, but group rejects it
Hamas is rejecting a new Israeli proposal to pause the war in Gaza, a Hamas official told NPR. Earlier, officials mediating talks had expressed optimism that a deal could be reached within weeks.
Higher ed war heats up as Trump threatens Harvard’s tax-exempt status
The president's comments came after the administration froze $2 billion in federal grants for Harvard after the university rejected what it saw as illegal government demands.
When an earthquake struck San Diego, these elephants formed an ‘alert circle’
When a 5.2 earthquake hit near San Diego yesterday, the San Diego Zoo Safari Park caught its elephants on video taking action to protect their young, forming what experts call an "alert circle."
A colossal squid is filmed in its natural habitat for the first time
Colossal squid are known to be elusive and likely avoid the bright and loud research equipment used underwater.
Mark Zuckerberg defends Meta in court against monopoly claims
In Zuckerberg's second day of testifying in the federal antitrust trial, he defended Meta's acquisitions of Instagram and WhatsApp. The U.S. government wants Meta to bust up the two companies.
